Cargando…
TTP: From empiricism for an enigmatic disease to targeted molecular therapies
The 100th anniversary of the first description of Thrombotic Thrombocytopenic Purpura (TTP) as a disease by Dr. Eli Moschcowitz approaches. For many decades, TTP remained mostly a mysterious fatal condition, where diagnosis was often post‐mortem. Initially a pentad of symptoms was identified, a patt...
Autores principales: | Graça, Nuno A. G., Joly, Bérangère S., Voorberg, Jan, Vanhoorelbeke, Karen, Béranger, Nicolas, Veyradier, Agnès, Coppo, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304236/ https://www.ncbi.nlm.nih.gov/pubmed/35146746 http://dx.doi.org/10.1111/bjh.18040 |
Ejemplares similares
-
ADAMTS13 conformation is closed in non-immune acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology
por: Joly, Bérangère S., et al.
Publicado: (2022) -
Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP
por: De Waele, Laure, et al.
Publicado: (2021) -
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
por: Hrdinová, Johana, et al.
Publicado: (2018) -
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
por: Hrdinová, Johana, et al.
Publicado: (2021) -
Diagnosis and follow‐up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay
por: Beranger, Nicolas, et al.
Publicado: (2020)